The Digital Biomanufacturing Market is anticipated to grow at an annualized rate of 18% till 2035, claims Roots Analysis
Wednesday, June 7, 2023
The necessity to achieve operational excellence, visibility, control and synchronization in bioprocessing, has prompted manufacturers to adopt digital technologies for biologics, which enables to produce better yield in faster timelines
LONDON, May 30, 2023 /PRNewswire/ -- Roots Analysis has announced the addition of "Digital Biomanufacturing Market, 2023-2035" report to its list of offerings.
https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg
Digital biomanufacturing harnesses various advancements, such as real-time monitoring, data analytics and process optimization to transform the available information into actionable insights. In the near future, this industry is anticipated to witness more investment and collaborations, while greater skillset among employees and adequate knowledge on operation will result in widespread adoption in the long run.
To order this 260 page report, which features 130+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
Key Market Insights
Over 100 organizations claim to be engaged in offering digital biomanufacturing solutions
This segment of the industry is dominated by the presence of software providers, which constitute 94% of the total number of stakeholders. It is worth mentioning that, amongst these, over 35% of the companies are small firms (2-51 employees).
Currently, process analytical technology (PAT) providers capture the highest share (50%) of the digital biomanufacturing market
Most of the process analytical technologies are intended to be deployed on-premises (52%), followed by cloud-based deployment (40%). In addition, 53% and 57% of the PAT and data analysis software (DAS) technologies, respectively, are used for manufacturing proteins.
40+ players are focused on providing manufacturing execution systems and digital twins
It is worth noting that over 95% of manufacturing execution systems can be integrated with software, such as enterprise resource planning (ERP). Further, 27% of digital twins providers offer smart manufacturing solutions to both industry and non-industry end users.
Partnership activity has increased significantly, with around 80% of deals inked in the last three years
Majority of the agreements related to digital biomanufacturing were instances of service alliances, representing 38% of the total partnerships. Further, most of the intercontinental, as well as intracontinental deals, have been inked by players based in Europe.
By 2035, the market for digital biomanufacturing is likely to grow at an annualized rate of 18%
In terms of type of technology, the current market is driven by PAT (close to 35%); this trend is unlikely to change in the foreseen future as well. Further, based on type of deployment options, majority of the revenue share (51%) of the overall market in 2035 is projected to be driven by on-premises deployment option.
Currently, Europe captures more than 38% share of the overall market
The digital biomanufacturing market in Asia-Pacific is projected to grow at a CAGR of 20%, till 2035. Further, in terms of type of biologic(s) manufactured, the current market is driven by antibodies (with close to 40% share). In addition, the digital biomanufacturing market for cell and gene therapies is anticipated to grow at a faster pace (CAGR of 20%), during 2023-2035.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/digital-biomanufacturing-market/request-sample.html
Key Questions Answered
-- What is the global market size of digital biomanufacturing?
-- Which are the top players in the global digital biomanufacturing market?
-- What are the factors driving the digital biomanufacturing market?
-- Which region has the highest market share in the global digital
biomanufacturing market?
-- What are the leading market segments in digital biomanufacturing market?
-- Which segment, in terms of deployment options, accounts for the largest
share in the global digital biomanufacturing market?
-- What are the partnership and collaboration trends in the digital
biomanufacturing domain?
-- What is the growth rate (CAGR) in the global digital biomanufacturing
market?
The financial opportunity associated with the digital biomanufacturing market has been analyzed across the following segments:
-- Type of Technology
-- Process Analytical Technology (PAT)
-- Data Analysis Software (DAS)
-- Manufacturing Execution Systems (MES)
-- Digital Twins
-- Deployment Options
-- Cloud-based Deployment Options
-- On-premises Deployment Options
-- Type(s) of Biologic(s) Manufactured
-- Antibodies
-- Cell and Gene Therapies
-- Proteins
-- Vaccines
-- Others
-- Geographical Regions
-- North America
-- Europe
-- Asia Pacific
-- Latin America
-- Middle East and North America
The report also features inputs from eminent industry stakeholders, according to whom, the continuously rising interest in digitalization and growing demand for biologics is likely to drive the growth of the digital biomanufacturing market. The report includes detailed transcripts of discussions held with the following experts:
-- Joel Sirois (President and Chief Executive Officer, BioIntelligence
Technologies)
-- Klaus Mauch (Managing Director and Chief Executive Officer, Yokogawa
Insilico Biotechnology)
-- Ciaran O'Keeffe (Director, Business Development and Channel Sales,
MasterControl) and Isura Sirisena (Quality and Manufacturing
Digitization Specialist, MasterControl)
-- Yaron Halfon (Director of Sales, Trunovate)
-- Barbara Holtz (Business Consultant, Dassault Systèmes)
The research includes profiles of key players (listed below) engaged in offering digital biomanufacturing technologies; each profile features a brief overview of the company, along with details related to its financial information, technology portfolio, recent developments and an informed future outlook.
-- AspenTech
-- Bioreactors.net
-- Dassault Systèmes
-- FUJIFILM Diosynth Biotechnologies
-- GE Healthcare
-- Körber
-- Merck
-- Sartorius
-- Thermo Fisher Scientific
For additional details, please visit
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
You may also be interested in the following titles:
1. Blockchain Technology in Healthcare Market: Industry Trends and Global
Forecasts, 2022-2035
2. Digital Twins Market: Industry Trends and Global Forecasts,2022-2035
3. Manufacturing Execution System Providers in Healthcare: Industry Trends
and Global Forecasts, 2022-2035
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Gaurav.chaudhary@rootsanalysis.com
Logo: https://mma.prnewswire.com/media/742223/Roots_Analysis_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/the-digital-biomanufacturing-market-is-anticipated-to-grow-at-an-annualized-rate-of-18-till-2035-claims-roots-analysis-301837324.html
SOURCE Roots Analysis
|
|
|
|
|
 |
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Marketing Evolution Announces New Investment Led by Insight Partners to Power AI-Ready Marketing Data for the Agentic Era | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
|
|
